Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Impact of androgen stimulation on BCL2 Overexpressed LNCaP cells

ABSTRACT: Impact of androgen stimulation on BCL2 Overexpressed LNCaP cells

PROVIDER: PRJNA1142952 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR30089010_1.fastq.gz	Fastqsanger.gz
	SRR30089010_2.fastq.gz	Fastqsanger.gz
	SRR30089011_1.fastq.gz	Fastqsanger.gz
	SRR30089011_2.fastq.gz	Fastqsanger.gz
	SRR30089012_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Impact of androgen stimulation on BCL2 Overexpressed LNCaP cells

Project description:In analyzing transcriptomic data from a clinical trial of neoadjuvant-intensive Androgen Deprivation Therapy, we observed increased mRNA expression of the hallmark antiapoptotic gene BCL2 in the prostate tumors of treated patients versus those of untreated patients. We showed that BCL2 overexpressed LNCaP cells exhibited resistance to enzalutamide, indicating that BCL2-overexpression leads to castration resistance and cellular plasticity.We performed RNA sequencing on BCL2 overexpressed LNCaP cells tretaed with R1881 to determine BCL2 regulated AR signaling and overed that BCL2 overexpression may alter AR-pathway.

2025-05-15 | GSE273737 | GEO

Impact of BCL2 inhibitor Venetoclax on LNCaP cells

Project description:In analyzing transcriptomic data from a clinical trial of neoadjuvant-intensive Androgen Deprivation Therapy, we observed increased mRNA expression of the hallmark antiapoptotic gene BCL2 in the prostate tumors of treated patients versus those of untreated patients. We showed that BCL2 overexpressed LNCaP cells exhibited resistance to enzalutamide, indicating that BCL2-overexpression leads to castration resistance and cellular plasticity.We treted the LNCaP cells with Bcl2 inhibitor Venetoclax in under castration of in presence of Androgen for 24 hr and observed that androgen supressed Venetoclax function

2025-05-15 | GSE273738 | GEO

Impact of BCL2 Overexpression in castration resistance prostate cancer progression I

Project description:In analyzing transcriptomic data from a clinical trial of neoadjuvant-intensive Androgen Deprivation Therapy, we observed increased mRNA expression of the hallmark antiapoptotic gene BCL2 in the prostate tumors of treated patients versus those of untreated patients. We showed that BCL2 overexpressed LNCaP cells exhibited resistance to prolonged androgen deprivation therapy, indicating that BCL2-overexpression leads to castration resistance and cellular plasticity.Our study indicating that BCL2 overexpression may act as a major driver of early castration resistance in prostate cancer cells.

2025-05-15 | GSE273736 | GEO

Androgen receptor RIME using LNCaP cells

Project description:Rapid immunoprecipitation mass spectrometry of endogenous protein (RIME) was conducted to examine interactome of androgen receptor (AR) in LNCaP cells.

2021-09-10 | PXD024030 | JPOST Repository

Transcriptome changes upon androgen deprivation and DHT stimulation in LNCaP cells

Project description:Transcriptome changes upon androgen deprivation and DHT stimulation in LNCaP cells

| PRJNA515892 | ENA

R1881 treatment modulates LNCaP proteome.

Project description:The androgen receptor is considered as the key promoter of prostate cancer. It is a transcription factor that controls the transcription of hundreds of its target genes. In this project we focuses on how androgen receptor stimulation by the synthetic androgen R1881 can affect the proteome of peroxiosmes and the antioxidant enzymes in LNCaP cells.

2024-11-01 | PXD054374 | Pride

Epigenomic and transcriptomic profiles a of prostate cancer cell line with and without androgen stimulation

Project description:We performed H3K27ac ChIP-seq, ATAC-seq, and RNA-seq in LNCaP with and without androgen stimulation

2022-06-14 | GSE205885 | GEO

Impact of BCL2 inhibitor Venetoclax on LNCaP cells

Project description:Impact of BCL2 inhibitor Venetoclax on LNCaP cells

| PRJNA1142953 | ENA

Transcriptome changes upon androgen deprivation and DHT stimulation in LNCaP cells

Project description:The transcription factor and RNA-interacting Y-box binding protein-1 (YB-1 protein, YBX1 gene) has gained interest as a prognostic biomarker and therapeutic target in various malignancies including prostate cancer. Using a custom prostate-cancer-focussed microarray platform, we have established a transcriptome-wide profile of YB-1 target transcripts in the androgen sensitive prostate cancer cell line LNCaP.

2022-01-17 | GSE125338 | GEO

Expression data from androgen treated LNCaP cells

Project description:Androgens are required for the development of normal prostate, and they are also linked to the development of prostate cancer. We used microarrays to understand the role of androgen in an androgen dependent, androgen receptor (AR) positive human metastatic cell line, LNCaP.

2009-12-30 | GSE17044 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data